These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9389984)

  • 1. Origin of hepatocellular carcinoma recurring after allotransplantation revealed by microsatellite analysis.
    Pfeiffer H; Ortmann C; Klein A; Brinkmann B
    J Clin Pathol; 1997 Sep; 50(9):792-4. PubMed ID: 9389984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of frequent allelic loss on 17p13.1 with early metastatic recurrence of hepatocellular carcinoma after liver transplantation.
    Zhou L; Zhou W; Wu L; Yu X; Xing C; Zheng S
    J Surg Oncol; 2010 Dec; 102(7):802-8. PubMed ID: 20886556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of chromosomal instability in pulmonary or liver metastases and matched primary hepatocellular carcinoma after orthotopic liver transplantation.
    Gross-Goupil M; Riou P; Emile JF; Saffroy R; Azoulay D; Lacherade I; Receveur A; Piatier-Tonneau D; Castaing D; Debuire B; Lemoine A
    Int J Cancer; 2003 May; 104(6):745-51. PubMed ID: 12640682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of clonal origin of recurrent hepatocellular carcinoma for personalized therapy and outcomes evaluation: a new strategy for hepatic surgery.
    Wang B; Xia CY; Lau WY; Lu XY; Dong H; Yu WL; Jin GZ; Cong WM; Wu MC
    J Am Coll Surg; 2013 Dec; 217(6):1054-62. PubMed ID: 24246620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular techniques for identifying HCC origin and biology after orthotopic liver transplantation.
    Mas VR; Maluf DG; Dumur CI; Archer KJ; Yanek K; Jackson-Cook C; Fisher RA
    Diagn Mol Pathol; 2006 Jun; 15(2):90-4. PubMed ID: 16778589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotyping of hepatocellular carcinoma in liver transplant recipients adds predictive power for determining recurrence-free survival.
    Marsh JW; Finkelstein SD; Demetris AJ; Swalsky PA; Sasatomi E; Bandos A; Subotin M; Dvorchik I
    Liver Transpl; 2003 Jul; 9(7):664-71. PubMed ID: 12827550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local therapy improvement of outcome in a patient with recurrent hepatocellular carcinoma after living donor liver transplantation: a case report.
    Shimokawa M; Itoh S; Ikegami T; Takeishi K; Harimoto N; Yamashita YI; Yoshizumi T; Kawanaka H; Shirabe K; Maehara Y
    Anticancer Res; 2015 Jun; 35(6):3525-9. PubMed ID: 26026120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic allelotyping for distinction of recurrent and de novo hepatocellular carcinoma after orthotopic liver transplantation.
    Altimari A; Gruppioni E; Fiorentino M; Petraroli R; Pinna AD; Petropulacos K; Ridolfi L; Costa AN; Grigioni WF; Grigioni AD
    Diagn Mol Pathol; 2005 Mar; 14(1):34-8. PubMed ID: 15714062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity at D14S62 and D14S51 detected by a simple and non-radioactive method in plasma DNA is a potential marker of metastasis and recurrence after curative hepatic resection in hepatocellular carcinoma.
    Niu Q; Tang ZY; Qin LX; Ma ZC; Zhang LH
    Hepatogastroenterology; 2003; 50(53):1579-82. PubMed ID: 14571790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrahepatic recurrence of hepatocellular carcinoma 13 years after orthotopic liver transplantation for hepatitis C-related cirrhosis with occult hepatocellular carcinoma: a case report.
    Nelson AC; Jessurun J; Peterson RK; Pambuccian SE
    Liver Transpl; 2012 May; 18(5):612-4. PubMed ID: 22344889
    [No Abstract]   [Full Text] [Related]  

  • 11. Disseminated tumor cells homing into rats' liver: a new possible mechanism of HCC recurrence.
    Li QG; Yang GS; Yang Q; Wei LX; Yang N; Zhou XP; Jia FQ
    World J Gastroenterol; 2004 Mar; 10(6):903-5. PubMed ID: 15040042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant DNA methylation profile of hepatocellular carcinoma and surgically resected margin.
    Lou C; Du Z; Yang B; Gao Y; Wang Y; Fang S
    Cancer Sci; 2009 Jun; 100(6):996-1004. PubMed ID: 19385975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular diagnosis of primary liver cancer by microsatellite DNA analysis in the serum.
    Chang YC; Ho CL; Chen HH; Chang TT; Lai WW; Dai YC; Lee WY; Chow NH
    Br J Cancer; 2002 Dec; 87(12):1449-53. PubMed ID: 12454776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo hepatocellular carcinoma in a liver graft with sustained hepatitis C virus clearance after living donor liver transplantation.
    Morita K; Taketomi A; Soejima Y; Ikegami T; Fukuhara T; Iguchi T; Nagata S; Sugimachi K; Gion T; Shirabe K; Maehara Y
    Liver Transpl; 2009 Nov; 15(11):1412-6. PubMed ID: 19877253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of SOX4 gene and early recurrence of hepatocellular carcinoma: their relationship and the clinical significance].
    Zheng JH; Jian ZX; Jin HS; Chen SC; Wang GY
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Apr; 30(4):818-9. PubMed ID: 20423819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Onset of de novo Hepatocellular Carcinoma after Liver Transplantation can be both of Donor and Recipient origin. A Case Report.
    Tamè M; Calvanese C; Cucchetti A; Gruppioni E; Colecchia A; Bazzoli F
    J Gastrointestin Liver Dis; 2015 Sep; 24(3):387-9. PubMed ID: 26405713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor miR-196a-2 polymorphism is associated with hepatocellular carcinoma recurrence after liver transplantation in a Han Chinese population.
    Xu X; Ling Q; Wang J; Xie H; Wei X; Lu D; Hu Q; Zhang X; Wu L; Zhou L; Zheng S
    Int J Cancer; 2016 Feb; 138(3):620-9. PubMed ID: 26365437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different DNA changes in primary and recurrent hepatocellular carcinoma.
    Ding SF; Jalleh RP; Wood CB; Bowles L; Delhanty JD; Dooley J; Habib NA
    Gut; 1992 Oct; 33(10):1433-5. PubMed ID: 1359992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between donor and recipient smoothened gene polymorphisms and the risk of hepatocellular carcinoma recurrence following orthotopic liver transplantation in a Han Chinese population.
    Wang P; Song W; Li H; Wang C; Shi B; Guo W; Zhong L
    Tumour Biol; 2015 Sep; 36(10):7807-15. PubMed ID: 25944162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of the human MIF promoter polymorphism on hepatocellular carcinoma prognosis.
    Yuan T; Tang C; Chen M; Deng S; Chen P
    Genet Mol Res; 2013 Jan; 12(4):6629-35. PubMed ID: 23315862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.